How to Do It: Utilizing Risk Stratification to Evaluate Outcomes in Adult Open-Heart Operations

Size: px
Start display at page:

Download "How to Do It: Utilizing Risk Stratification to Evaluate Outcomes in Adult Open-Heart Operations"

Transcription

1 THE JouRNAl OF ExTRA-CoRPOREAl TECHNOlOGY Original Article Presented at the AmSECT 30th International Conference March 13-16, 199, Washington, D.C. How to Do It: Utilizing Risk Stratification to Evaluate Outcomes in Adult Open-Heart Operations Timothy A. Dickinson, CCP, MHA Desert Springs Hospital, Las Vegas, Nevada Keywords: database, risk stratification, open heart surgery Abstract The purpose of this study is to demonstrate that by using a proven method of stratifying open-heart operations into levels of predicted mortality, hospitals can closely monitor trends of their open-heart programs and possibly improve the health planning decisions for their institution. A proven method of uniform risk stratification utilizing objective and readily available preoperative patient data was implemented at our institution for a 1 month period (September I, 1991 through August 31, 199). A total of 367 patients were included in this study. The patients were categorized into four risk ranges (0 to 4% good risk, to 9% fair risk, to 14% poor risk, and :?:1% high risk) indicating a predictive percent probability of operative mortality. The number patients categorized as either 0 to Introduction The Wall Street J oumal reported in December of 1991 that health expenditures are expected to climb to a record 14% of our nation's total gross national product (GNP) for 199. The article also stated that overall health expenditures will continue to increase at an average annual rate of 1% to 13% during the next five years (I). Unarguably, open-heart surgery is expensive and represents a substantial percentage in total Address correspondence to: Timothy A. Dickinson, CCP, MHA Department of Perfusion Services Desert Springs Hospital 07 East Flamingo Road Las Vegas, NV % good risk, to 9% fair risk, to 14% poor risk, and :?:1% high risk were46, 74, 84and 163, respectively. The patient's average post -operative length of stay in each risk category was 7.6 days, 8. days, days and 1 days, respectively. The patient's average total hospital charges in each risk category were $48,41,$3,31,$60,416 and $7,, respectively. This information has helped our hospital administration make relevant and objective decisions concerning our open-heart program. Uniform risk stratification( outcomes research) should be incorporated into all adult open-heart surgery programs because it is simple, inexpensive, and can evaluate the outcomes and cost of open-heart surgery. health care expenditures. The 1990 average hospital charge per admission for coronary bypass surgery in the four openheart programs in Las Vegas, Nevada ranged from $7,634 to $76,30. These figures represent an average increase of 1.8% over 1989 levels (). Factors that influence the cost of openheart surgery are the duration of hospitalization, the severity of illness, and the complexity and intensity of care (3). It is no wonder that those who pay for health care, such as insurance companies and Medicare, are deeply interested in the costs and benefits of open-heart procedures. In 1986, the Health Care Financing Administration (HCFA) began publicly reporting mortality results in the Medicare population ( 4). Today these reports list hospitals by region and specifically show data representing the results of open-heart surgery in the Medicare population (). Until recently, an inherent difficulty in comparing the results of open-heart surgery 13 Vol. 4 No. 4, 7 993

2 THE JouRNAL OF ExTRA-CoRPOREAL TECHNOLOGY Legend: for Table 1 BP=blood pressure. IABP=intra-aortic balloon pump. PTCA=percutaneous transluminal coronary angioplasty. PD=peritoneal dialysis. Hemo=hemodialysis. PA=pulmonary artery. AV=aortic valve. HD=heart disease. PA=pulmonary artery. CABG=coronary artery bypass graft. Vent=ventri cu lar. T ach=tachycardi a. Fi b=fi bri II ation. UO=urine output. Ml=myocardial infarction. CHF=congestive heart failure. CR=Creatinine. COPD=chronic obstructive pulmonary disease. PAP=pulmonary artery pressure. CVA=cerebral vascular accident. MS=muscular dystrophy. HDL=high-density lipoprotein. HIV=human immunodeficiency virus. between surgeons and institutions is the lack of a simple and widely accepted method of quantifying patient risk that defines the severity of disease and identifies the many variables that contribute to a predictable outcome. The HCFAreport, for example, represents raw mortality data for Medicare patients undergoing coronary artery bypass grafting procedures while omitting many of the risk factors associated with predictably poor outcomes. There is a simple and effective way of quantifying risk thus allowing a fair comparison of different institutions' results. Dr. Parsonnet et al described a method of stratifying openheart procedures into levels of predicted operative mortality (3). This methodology was based upon preoperative, objective risk factors that are readily available in any hospital. The risk factors and their assigned weight were generated from various statistical methods including univariate and multivariate logistic-regression analyses. The criteria for including a risk variable included (3): 1) Predictive value must be demonstrated by univariate analysis; ) Data must be available for every patient; 3) Data must be available at every institution; 4) The variable must be as free as possible from subjectivity or bias; and ) The variable must be simple and direct (not derived from other information).* The predictive operative mortality is computed by summing all the individual risk factors. The predicted probability of operative mortality can be stratified into ranges reflecting a patient's expected mortality rate: good risk (0-4% ), fair risk (-9%), poor risk (-14%), high risk (~1%). The before mentioned ranges with their respective title (i.e. good risk, fair risk, etc.) were contrived by Dr. Parsonnet, et al. A comparison of predicted and observed outcomes for each of the risk ranges reveals a close correlation using various statistical methods. * Reprinted with permission. Circulation 1989 Supplement 1; 3: Table 1 Revised risk factors and their respective weights Risk Factor Female Gender Morbid obesity (;:::1. x ideal weight) Diabetes (unspecified type) Hypertension (systolic BP>l40mmHg) Ejection Fraction(%): Good (;:::SO) Fair (30-49) Poor (<30) Age (yr): ;:::so Reoperation First Second Preoperative IABP Left ventricular aneurysm resected Emergency surgery following PTCA or catheterization complications Dialysis dependency (PD or Hemo) Valve surgery: Mitral (PA systolic <9mmHg) Mitral (PA pressure ;:::60mmHg) Aortic (A V gradient< mmhg) Aortic (Pressure gradient ;:::I0mmHg) Tricuspid CABG at the time of valve surgery Cardiac conditions: Left main disease; unstable angina Vent. Tach.Nent. Fib. aborted sudden death Assigned Weight I Cardiogenic shock (UO <IOcc/hr) Transmural MI (within 48 hours) 7 Chronic CHF (peripheral edema, pleural effusion) Pacemaker dependent Aortic regurgitation, acute Mitral regurgitation, acute Ventricular septal defect, acute 0 Constrictive pericarditis Congenital heart disease in adult, cyanotic I 0 Hepato-Renal conditions: Renal Failure, chronic (CR>, without dialysis) Renal Failure, acute Cirrhosis of liver (serum bilirubin >) Pulmonary Conditions: COPD, severe Pulmonary hypertension (mean PAP >30mmHg) Idiopathic thrombocytopenic purpura Endotracheal tube, pre-operation Asthma (peak expiratory flow rate <1 00) 0 Asthma (peak expiratory flow rate <00) Vascular Conditions: Peripheral vascular disease, severe Carotid disease, unilateral occlusion Carotid disease, bilateral Abdominal aortic aneurysm, asymptomatic Dissecting Thoracic Aneurysm Miscellaneous conditions Severe neurological disorder (healed CV A, paraplegia, M.S., hemiparesis) Diabetes, Juvenile Hyperlipidemia (cholesterol >300, HDL <30) 3 Jehovah's Witness Cold Agglutinins Aspirin prescription Substance abuse (alcohol, drugs), severe 3 AIDS, Active disease (HIV positive excluded) Active neoplasm (leukemia, lymphoma, etc.) High dose steroids, active TOTAL POINTS Vol. 4 No. 4,

3 THE JouRNAL of ExTRA-CoRPOREAL TECHNOLOGY (Personal Communication with Dr. Parsonnet, et al Letter; January, 199). The risk stratification method first described by Dr. Parsonnet has since been extended to include more preoperative variables that can be used in predicting risk(table 1 ). This modification eliminated potential interpretational variances. (Personal Communication with Dr. Parsonnet, M.D. Letter; July 30, 1991). Material and Methods: For the purposes of the present study further information rele~ant to our program (i.e. surgeon's name, anesthesiologist name, cardiologist's name, perfusionist's name, hospital number, procedure, and date of surgery), were included with the variables shown in Table 1. On September 1, 1991, Dr. Parsonnet's risk stratification method was implemented into the open-heart surgery program at Desert Springs Hospital, Las Vegas, Nevada. All members of the perfusion staff were instructed to record on the perfusion record all the patient's preoperative risk factors shown in Table 1. At the end of each month, the data from the perfusion records were entered into a database program. As of August 31, 199, (1 month period) 367 open-heart procedures were recorded in this database. The material used to conduct this risk stratification study included the following items: I. Hardware A) Apple Macintosh SE II. Software A) FileMaker Prob database program B) Microsoft Excelc spreadsheet program Results: The database was queried in order to provide information concerning the relationship between preoperative patient risk factors and postoperative patient outcome. Figure 1 shows the distribution of open-heart surgery patients versus their preoperative risk classification and predicted percent probability of operative mortality. For the 1 month period ending August 31, 199; 46, 7 4, 84, and 163 patients were categorized as either 0 to 4% good risk, to 9% fair risk, to 14% poor risk, and ~1% high risk, respectively. High risk patients, defined as those patients with a ~1% predicted mortality, accounted for 44% (163/367) of the total cardiac surgery population. Figure compares the duration of postoperative hospitalization to the preoperative risk classification and predicted a Apple Computer Inc., Cuppertino, CA 9014 b Claris Corporation, Santa Clara, CA 90 c Microsoft Corporation, Redmond, CA 980 Figure 1 Distribution by Operative Risk Classification of Cardiac Surgery Patients (n=367). Number of Patients Distribution by Operative Risk Oassification of Cardaic Surgery Patients (n-367) [ ~---- -r 0 to 4% Good to 9% Fair to 14% Poor 1 %+ H1gh Pr00pe,ative Risk Classification by Predicted Percent Probability of Operative Mortality percent probability of operative mortality. The patients categorized as either 0 to 4% good risk, to 9% fair risk, to 14% poor risk, and~ 1% high risk had average postoperative length of stays of 7.6 days. 8. days, days and 1 days, respectively. The average postoperative length of stay for all patients was. days Figure 3 contrasts the average hospital charges to the preoperative risk classification and predicted percent probability of operative mortality. The patients categorized as eithero to4% goodrisk, to9% fair risk, loto 14% poor risk, and ~1% high risk had average hospital charges of$48,41, $3,31,$60,416,$7,, respectively. The average hospital charge for all patients was $64,. Discussion: The collected data has benefited our hospital in many different ways. This information has helped our hospital administration make relevant and objective decisions concerning our open-heart program. Our hospital is involved with capitated open-heart surgery contracts (i.e. contracts that pay the physician and hospital a flat fee regardless of severity of illness). The database was further queried in order to provide outcome data for individual physicians. It is vitally important to any open-heart program that enters into a capitated health care plan to choose cardiac surgeons and cardiologists that have proven skills to provide quality and cost-effective care for patients in all levels of risk. The collected data has helped 137 Vol. 4 No. 4, 1993

4 THE journal OF ExTRA-CORPOREAl TECHNOlOGY Figure Preoperative Risk Classification Versus Duration of Postoperative Hospitilization (n=367). Preoperative Risk Classification Versus Duration of Postoperative Hospitalization (n=367) 1 8 length of Stay (Days) j i 0 to 4% Good to 9% Fair 1 0 to 1 4% Poor 1%+ High Preoperative Risk Classification by Predicted Percent Probability of Operative Mortality Figure 3 Preoperative Risk Classification Versus Total Hospital Charges (n=367). Preoperative Risk Classification Versus Total Hospital Charges (n=367) 80,000,- 70,000 60,000 0,000 Hospital Charge (in dollars) ' 30,000 0,000, to 4% Good to 9% Fair to 14% Poor 1%+ High Preoperative Risk Classification by Predicted Percent Probability of Operative Morta6ty Vol. 4 No. 4,

5 THE journal OF EXTRA-CORPOREAL TECHNOLOGY our hospital administration select cardiac surgeons and cardiologists for our capitated health care plans. Another advantage of using Dr. Parsonnet's model has been the heightened awareness by both the cardiac surgeon and cardiologist that they are being closely monitored in regards to their medical practice. The risk stratification (outcomes) data is periodically presented at monthly cardiovascular services committee meetings which are attended by staff cardiologists, staff cardiac surgeons and one or more representatives from our hospital administration staff. This level of accountability, with additional pressure from our hospital administration, has led some of the cardiologists to send some of their elective high-risk open-heart patients to tertiary care centers, rather than referring them for surgery in our community hospital. Furthermore, some of the cardiac surgeons are refusing to operate on extremely high-risk patients referred for elective open-heart surgery. The end result of this analysis at our institution is an openheart program that includes improved physician involvement. It is an open-heart program that will almost assuredly be profitable and provide high quality care with acceptable mortality and morbidity statistics. On a national level we are in agreement with Dr. Clark who states that "It is time for a national cardiothoracic surgical database" (6). Some of the reasons given for the generation of this database include: * 1) The Liability Committee of the Society of Thoracic Surgeons (STS) has revealed that misrepresentation and misconception of operative risks are leading causes of malpractice actions. ) The Standards and Ethics Committee of the STS has shown that in some cases the hospitals, the cardiologists, and the surgeons have not recognized the changing patterns of patient populations receiving coronary artery bypass grafting procedures. This has been especially true with development of newer catheter intervention techniques, thrombolysis, and revascularization in the setting of acute myocardial ischemia. These circumstances have helped to perpetuate the prevalent professional and public perception that coronary artery operations carry little or no risk. 3) The Joint Commission on Accreditation of Health Care Organizations (JCAHO) has made it a requirement to have quality assurance programs for every segment of the health care system. Recredentialing on an annual basis is based on Reprinted with permission from the Society of Thoracic Surgeons (The Annals of Thoracic Surgery, 1989;48: the surgeon's results from the previous year. * As mentioned earlier HCFA's evaluations of open-heart programs fall short of being reasonable. The HCFA report predicts operative mortality without using many of the risk factors associated with predictably poor outcomes. For this reason, a system of uniform risk stratification( outcomes research) needs to be initiated now by all open-heart programs. Dr. Parsonnet and colleagues have gone a long way in providing a straightforward method for categorizing heart surgery patients preoperatively into various risk groups. His data shows that a prospective score is found to be highly predictive of operative mortality and closely relates to the overall complication rate and duration of postoperative hospitalization. If such a system was applied more universally it might be possible to compare outcomes of open-heart surgery at any institution. Comparisons between individual cardiac surgeons would also be possible. This type of analysis would also provide a basis for a meaningful informed consent or reveal an operative risk that is unacceptably high. As hospitals and cardiac surgeons enter into capitated health care contracts, the need to analyze the open-heart surgery program's patient selection and patient outcome will be increased. The widespread presence of coronary artery disease, the rapid growth of cardiac surgical programs across this country(?), the development of alternative interventional therapies, and an aging population have encouraged an increasing number of cardiac surgeons to treat high-risk patients even though manpower and hospital-based resources may be limited. Identifying preoperatively, those patients that fall into high-risk groups may provide useful information to the attending cardiac surgeon, the patient and family members. Acknowledgments: The author wishes to express his deep appreciation to his brother Chris J. Dickinson, MD, for his constructive criticisms and encouragement. The author also wishes to thank Jack Prichard, CCP and Faye Rieckens, CCP for their assistance in collection of the data and for their review of this article. References 1. Bangdanich W. Health expenditures expected to climb to record 14% of U.S. output in 199. Wall Street Journal. 1991; Dec 30: A.. Bureau of Health Planning. Personal Health Choices State of Nevada Department of Human Resources Division of Health. 4th Edition, November Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired heart disease. Circulation Supplement 1 ;79: Vol. 4 No. 4, 1993

6 THE JouRNAL of ExTRA-CORPOREAL TEcHNOLOGY 4. Rosen HM, Green BA. The HCFA excess mortality lists: A methodological critique. Hosp Health Ser Admin. 1987;3: Medicare Hospital Mortality Information 1987, 1988, Volume 1 U.S. Department of Health and Human Services. Health Care Financing Administration. HCFA Pub. No Clark, R. It is time for a national cardiothoracic surgical data base. Ann Thorac Surg. 1989;48: Souhrada, L. Hospitals pursue heart programs-despite pitfalls. Hospitals. Oct. 0, 1989: Vol. 4 No. 4,

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity? Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

EACTS Adult Cardiac Database

EACTS Adult Cardiac Database EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005

Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005 Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005 The Pennsylvania Health Care Cost Containment Council April 2007 Preface This document serves as a technical supplement to

More information

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty

More information

Local Coverage Determination (LCD) for Cardiac Catheterization (L29090)

Local Coverage Determination (LCD) for Cardiac Catheterization (L29090) Local Coverage Determination (LCD) for Cardiac Catheterization (L29090) Contractor Information Contractor Name First Coast Service Options, Inc. Contractor Number 09102 Contractor Type MAC - Part B LCD

More information

Risk Stratification Using The Society of Thoracic Surgeons Program

Risk Stratification Using The Society of Thoracic Surgeons Program Risk Stratification Using The Society of Thoracic Surgeons Program Brack G. Hattler, MD, PhD, Carol Madia, PA, Carol Johnson, CRNP, John M. Armitage, MD, Robert L. Hardesty, MD, Robert L. Kormos, MD, Si

More information

Analysis of Mortality Within the First Six Months After Coronary Reoperation

Analysis of Mortality Within the First Six Months After Coronary Reoperation Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic

More information

THE journal OF EXTRA-CORPOREAL TECHNOLOGY

THE journal OF EXTRA-CORPOREAL TECHNOLOGY Original Article A Comparison of the Benefits of Roller Pump Versus Constrained Vortex Pump in Adult Open Heart Operations Utilizing Outcomes Research Timothy A. Dickinson, MHA, CCP, Jack Prichard, BS,

More information

Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager

Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition

More information

Rhythm Disorders 2017 TazKai LLC and NRSNG.com

Rhythm Disorders 2017 TazKai LLC and NRSNG.com Rhythm Disorders 1. Outline the conduction system of the heart. 2. What do the different portions of the EKG represent? 3. Define the following terms: a. Automaticity b. Conductivity c. Excitability d.

More information

Setting The setting was a hospital. The economic study was carried out in Australia.

Setting The setting was a hospital. The economic study was carried out in Australia. Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

Surgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents

Surgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at

More information

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational Medical Knowledge Goals and Objectives PF EF MF LF Aspirational Know the basic principles of magnetic resonance imaging (MRI) including the role of the magnetic fields and gradient coil systems, generation

More information

Intraoperative application of Cytosorb in cardiac surgery

Intraoperative application of Cytosorb in cardiac surgery Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)

More information

Appendix 1: Supplementary tables [posted as supplied by author]

Appendix 1: Supplementary tables [posted as supplied by author] Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial

More information

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient

More information

(Ann Thorac Surg 2008;85:845 53)

(Ann Thorac Surg 2008;85:845 53) I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable

More information

Section 6 Intra Aortic Balloon Pump

Section 6 Intra Aortic Balloon Pump Section 6 Intra Aortic Balloon Pump The Intra Aortic Balloon Pump (IABP) The balloon is synthetic and is made for single use only. It is threaded into the aorta, usually via a femoral approach. The balloon

More information

CY2015 Hospital Outpatient: Endovascular Procedure APCs and Complexity Adjustments

CY2015 Hospital Outpatient: Endovascular Procedure APCs and Complexity Adjustments CY2015 Hospital Outpatient: Endovascular Procedure APCs Complexity Adjustments Comprehensive Ambulatory Payment Classifications (c-apcs) CMS finalized the implementation of 25 Comprehensive APC to further

More information

The American Experience

The American Experience The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior

More information

Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting

Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting Tuula S. O. Kurki, MD, and Matti Kataja, PhD Heart Center, Deaconess Hospital, and National Public Health Institute,

More information

DUKECATHR Dataset Dictionary

DUKECATHR Dataset Dictionary DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

Ischemic Ventricular Septal Rupture

Ischemic Ventricular Septal Rupture Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor

More information

THE NATIONAL QUALITY FORUM

THE NATIONAL QUALITY FORUM THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use

More information

A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery

A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,

More information

Peripheral and Cardiology Coder 2018

Peripheral and Cardiology Coder 2018 Peripheral and Cardiology Coder 2018 Cardiovascular Services and Procedures Prepared and Published By: MedLearn Publishing A Division of MedLearn Media, Inc. 445 Minnesota Street, Suite 514 St. Paul, MN

More information

Outcome of elderly patients with severe but asymptomatic aortic stenosis

Outcome of elderly patients with severe but asymptomatic aortic stenosis Outcome of elderly patients with severe but asymptomatic aortic stenosis Robert Zilberszac, Harald Gabriel, Gerald Maurer, Raphael Rosenhek Department of Cardiology Medical University of Vienna ESC Congress

More information

SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY

SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY PS1070 SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY TITLE: ADMISSION/DISCHARGE CRITERIA: CARDIOVASCULAR INTENSIVE Job Title of Reviewer: Director, CVICU EFFECTIVE DATE: REVIEWED/REVISED DATE: POLICY

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

Diagnostic & Therapeutic Cardiac Catheterization Coder 2017

Diagnostic & Therapeutic Cardiac Catheterization Coder 2017 Diagnostic & Therapeutic Cardiac Catheterization Coder 2017 Including peripheral and cardiovascular services and procedures Prepared and Published By: MedLearn Publishing A Division of Panacea Healthcare

More information

National Intervention Council

National Intervention Council National Intervention Council Cardiological Society of India Registry Performa for Coronary, Non- Coronary & Peripheral Interventions Period January 1st 2016 to December 31 st 2016 Dr. (Prof.) N.N. Khanna

More information

CMS Limitations Guide - Radiology Services

CMS Limitations Guide - Radiology Services CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018 Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac

More information

Complications of Acute Myocardial Infarction

Complications of Acute Myocardial Infarction Acute Myocardial Infarction Complications of Acute Myocardial Infarction Diagnosis and Treatment JMAJ 45(4): 149 154, 2002 Hiroshi NONOGI Director, Division of Cardiology and Emergency Medicine, National

More information

CY2017 Hospital Outpatient: Vascular Procedure APCs and Complexity Adjustments

CY2017 Hospital Outpatient: Vascular Procedure APCs and Complexity Adjustments CY2017 Hospital Outpatient: Vascular Procedure APCs and Complexity Adjustments Comprehensive Ambulatory Payment Classifications (c-apcs) In CY2015 and in an effort to help pay providers for quality, not

More information

Lnformation Coverage Guidance

Lnformation Coverage Guidance Lnformation Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity Abstract: B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It

More information

Balloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C

Balloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C Balloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C Record Status This is a critical abstract of an economic evaluation that meets

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Pinpoint & properly assign the appropriate heart failure codes Left- vs. Right-sided Left ventricular failure (LVF) may

More information

Introducing the COAPT Trial

Introducing the COAPT Trial physician INFORMATION Eligible patients Symptomatic functional mitral regurgitation 3+ Not suitable candidates for open mitral valve surgery NYHA functional class II, III, or ambulatory IV Introducing

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

APPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10

APPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10 Ross JS, Bernheim SM, Lin Z, Drye EE, Chen J, Normand ST, et al. Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood).

More information

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees

More information

ORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery

ORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative

More information

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card 2014: Reference Mapping Card 162.3 Malignant neoplasm upper lobe lung 162.5 Malignant neoplasm lower lobe lung 162.9 lung/bronchus 396.2 396.3 Mitral insufficiency, aortic stenosis Mitral aortic valve

More information

The Ross Procedure: Outcomes at 20 Years

The Ross Procedure: Outcomes at 20 Years The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:

More information

Preoperative tests (update)

Preoperative tests (update) National Institute for Health and Care Excellence. Preoperative tests (update) Routine preoperative tests for elective surgery NICE guideline NG45 Appendix C: April 2016 Developed by the National Guideline

More information

TECHNICAL NOTES. for the Cardiac Surgery Report

TECHNICAL NOTES. for the Cardiac Surgery Report TECHNICAL NOTES for the Cardiac Surgery Report September 2013 Pennsylvania Health Care Cost Containment Council Report Period: July 1, 2011 through December 31, 2012 225 Market Street, Suite 400, Harrisburg,

More information

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu

More information

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,

More information

The importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher

The importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher The importance of follow-up after a cardiac event: CARDIAC REHABILITATION Dr. Guy Letcher The National Medicare Experience Mortality After Angioplasty 225,915 patients Mortality After Bypass Surgery 357,885

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

Adult Cardiac Surgery

Adult Cardiac Surgery Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

2015 Facility and Physician Billing Guide Heart Valve Technologies

2015 Facility and Physician Billing Guide Heart Valve Technologies 2015 Facility and Physician Billing Guide Heart Valve Technologies PHYSICIAN BILLING CODES Clinicians use Current Procedural Terminology (CPT 1 ) codes to bill for procedures and services. Each CPT code

More information

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Abha'Khandelwal,'MD,'MS' 'Stanford'University'School'of'Medicine'

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This

More information

Form 136 WHI WOMEN S HEALTH INITIATIVE HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

Form 136 WHI WOMEN S HEALTH INITIATIVE HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM Form 136 WHI WOMEN S HEALTH INITIATIVE HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM FORM NAME: H T F DATE: 10/31/2012 VERSION: A MEMBER ID NUMBER: General Instructions: This form should be completed

More information

Cardiac surgery in Victorian public hospitals, Public report

Cardiac surgery in Victorian public hospitals, Public report Cardiac surgery in Victorian public hospitals, 2009 10 Public report Cardiac surgery in Victorian public hospitals, 2009 10 Public report Authors: DT Dinh, L Tran, V Chand, A Newcomb, G Shardey, B Billah

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

In Pursuit of Excellence: The CheckPoint Journey

In Pursuit of Excellence: The CheckPoint Journey Focus On Quality... In Pursuit of Excellence: The CheckPoint Journey Charles Shabino, MD; Dana Richardson, RN, MHA Abstract In March 2004, the Wisconsin Hospital Association launched CheckPoint sm (www.wicheckpoint.org)

More information

STS CABG Composite Quality Rating. Participant STS Period Ending 12/31/2016

STS CABG Composite Quality Rating. Participant STS Period Ending 12/31/2016 STS CABG Composite Quality Rating Quality Participant Score STS Mean Participant Distribution of Participant Scores Domain (98% CI) Participant Score Rating = STS Mean Jan 06 - Dec 06 Overall Jan 06 -

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

In Process, Unpublished STS/ACC TVT Registry Manuscripts

In Process, Unpublished STS/ACC TVT Registry Manuscripts In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart

More information

Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia

Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties

More information

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland

More information

Contrast Induced Nephropathy

Contrast Induced Nephropathy Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

More information

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg Rotation: or: Faculty: Coronary Care Unit (CVICU) Dr. Jeff Rottman Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg Duty Hours: Mon Fri, 7 AM to 7 PM, weekend call shared with consult

More information

Do Now. Get out work from last class to be checked

Do Now. Get out work from last class to be checked Do Now Get out work from last class to be checked Heart Actions Cardiac Cycle: One complete heartbeat. The contraction of a heart chamber is called systole and the relaxation of a chamber is called diastole.

More information

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87

More information

Chronic Primary Mitral Regurgitation

Chronic Primary Mitral Regurgitation Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,

More information

Alex versus Xience Registry Preliminary report

Alex versus Xience Registry Preliminary report Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor

More information

Coronary Artery Bypass Graft (CABG) Surgery 2002 Data. Technical Notes

Coronary Artery Bypass Graft (CABG) Surgery 2002 Data. Technical Notes Coronary Artery Bypass Graft (CABG) Surgery 2002 Data Technical Notes The Pennsylvania Health Care Cost Containment Council February 2004 TABLE OF CONTENTS Outcome Measures Reported... 1 Study Population...

More information

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Risk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery

Risk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Risk Score for Predicting In-Hospital/3-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Edward L. Hannan, PhD, Michael Racz, PhD, Alfred T. Culliford, MD, Stephen

More information

The emergence of health maintenance organizations

The emergence of health maintenance organizations Predictors of 30-Day Hospital Readmission After Coronary Artery Bypass Robert D. Stewart, MD, Christian T. Campos, MD, Beth Jennings, BA, S. Scott Lollis, BA, Sidney Levitsky, MD, and Stephen J. Lahey,

More information

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict

More information

Atlas of Practical Cardiac Applications of MRI

Atlas of Practical Cardiac Applications of MRI Atlas of Practical Cardiac Applications of MRI Atlas of Practical Cardiac Applications of MRI Guillcm Pons-LIado, MD. Director, Cardiac Imaging Unit, Cardiology Department, Hospital de la Santa Creu i

More information

Covered Critical Illness Conditions Appendix

Covered Critical Illness Conditions Appendix Covered Critical Illness Conditions Appendix Effective Date: February 1, 2010 This Appendix contains definitions for those Conditions that are covered under the Manulife Financial Group Critical Illness

More information

Preoperative Management. Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee

Preoperative Management. Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Preoperative Management Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Perioperative Care Consideration Medical care provided to prepare

More information

PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS:

PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS: 1 NAME: DATE OF BIRTH PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS: PAST MEDICAL HISTORY (YOUR MEDICAL HISTORY) :

More information

2017 Cardiology Survival Guide

2017 Cardiology Survival Guide 2017 Cardiology Survival Guide Chapter 4: Cardiac Catheterization/Percutaneous Coronary Intervention A cardiac catheterization involves a physician inserting a thin plastic tube (catheter) into an artery

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information